Response to Comments: MolDX DecisionDX Uveal Melanoma

This document records the response-to-comments and administrative timeline for the MolDX DecisionDx-UM (Uveal Melanoma) Local Coverage Determination DL37070, including comment, notice, and final effective dates. It does not itself specify clinical coverage, limitations, documentation, or frequency criteria; stakeholders should consult LCD DL37070 for the detailed coverage policy.

"This document is a response to comments for the MolDX DecisionDx-UM (Uveal Melanoma) Local Coverage Determination DL37070; public comment period 02/08/2017–04/10/2017, notice period 08/07/2017–09/2..."

Sign up to see full coverage criteria, indications, and limitations.